119 related articles for article (PubMed ID: 7301649)
1. [Biological availability of sulfadimethoxine in the treatment of skin diseases].
Nowak A; Kadyków M; Klimowicz A
Pol Tyg Lek; 1981 Jul; 36(27):1015-8. PubMed ID: 7301649
[No Abstract] [Full Text] [Related]
2. [Sulfadimethoxine pharmacokinetics in chronic nephritis with nephrotic syndrome].
Bobrov VI; Segel'man VS; Iakovlev VP
Antibiotiki; 1981 Dec; 26(12):936-8. PubMed ID: 7325625
[TBL] [Abstract][Full Text] [Related]
3. [Clinical pharmacology of sulfadimethoxine].
Kadyków M
Pol Tyg Lek; 1987 Jan; 42(2):47-50. PubMed ID: 3588396
[No Abstract] [Full Text] [Related]
4. [Treatment of dysentery with sulfadimethoxine (madribon)].
Nikonov VA; Ustinova LA; Trusova SN; Vytchikova AM
Sov Med; 1972 May; 35(5):66-8. PubMed ID: 5042691
[No Abstract] [Full Text] [Related]
5. [Benign course of paracoccidioidomycosis of possible cutaneous inoculation].
Proença NG; Castro RM; Alonso FF
AMB Rev Assoc Med Bras; 1981 Jun; 27(6):170-2. PubMed ID: 6977144
[No Abstract] [Full Text] [Related]
6. Dissolution of slightly soluble drugs. VI. Effect of particle size of sulfadimethoxine on the oral bioavailability.
Watari N; Hanano M; Kaneniwa N
Chem Pharm Bull (Tokyo); 1980 Jul; 28(7):2221-5. PubMed ID: 7448955
[No Abstract] [Full Text] [Related]
7. [Use of biomycin electrophoresis in the treatment of suppurative skin diseases].
Iudkevich PA
Vestn Dermatol Venerol; 1968 Jun; 42(6):76-7. PubMed ID: 5747781
[No Abstract] [Full Text] [Related]
8. Degradation kinetics of manure-derived sulfadimethoxine in amended soil.
Wang Q; Guo M; Yates SR
J Agric Food Chem; 2006 Jan; 54(1):157-63. PubMed ID: 16390193
[TBL] [Abstract][Full Text] [Related]
9. [Ultralan in the therapy of certain skin diseases].
Makovoz VI
Vestn Dermatol Venerol; 1970 Jun; 44(6):80-1. PubMed ID: 5496843
[No Abstract] [Full Text] [Related]
10. Sulfadimethoxine degradation kinetics in manure as affected by initial concentration, moisture, and temperature.
Wang QQ; Bradford SA; Zheng W; Yates SR
J Environ Qual; 2006; 35(6):2162-9. PubMed ID: 17071885
[TBL] [Abstract][Full Text] [Related]
11. [Use of triamcinolone in alternate days in some skin diseases].
Tardin F; Neves RG; Padilha-Gonçalves A
Rev Bras Med; 1968 Oct; 25(10):668-70. PubMed ID: 5719712
[No Abstract] [Full Text] [Related]
12. [Therapy of skin diseases with Hameran cream].
Sotomatsu S; Yoshida K; Okamura K; Matsuki M
Hifuka Kiyo; 1966 May; 61(2):117-21. PubMed ID: 4164332
[No Abstract] [Full Text] [Related]
13. [Evaluation of BP-400, a preparation used in some skin diseases].
Kostrzewa J
Przegl Dermatol; 1970; 57(6):779-84. PubMed ID: 5502399
[No Abstract] [Full Text] [Related]
14. [The treatment of chronic dermatoses with glucocorticoids from the Belupo firm].
Tarasenko GN; Patronov IV; Tarasenko IuG
Voen Med Zh; 2000 Jan; 321(1):60-1. PubMed ID: 10701355
[No Abstract] [Full Text] [Related]
15. The use of Cordran tape in skin diseases.
Tilley JC; Graves TW
J La State Med Soc; 1969 Jun; 121(6):189-90. PubMed ID: 5789268
[No Abstract] [Full Text] [Related]
16. [Therapeutic results of intralesional hydrocortisone injections in various skin diseases].
Bogucka H
Przegl Dermatol; 1965; 52(5):509-15. PubMed ID: 5863412
[No Abstract] [Full Text] [Related]
17. [Clinical use of Decadron-S].
Tachibana K; Yamada M; Hayakawa M; Ikeda T
Hifuka Kiyo; 1966 May; 61(2):122-8. PubMed ID: 6007125
[No Abstract] [Full Text] [Related]
18. Indomethacin in certain dermatologic disorders.
Fleischmajer R; Goldstein J
Curr Ther Res Clin Exp; 1966 Sep; 8(9):452-4. PubMed ID: 4957932
[No Abstract] [Full Text] [Related]
19. [Chloroquine in the treatment of porphyria cutanea tarda symptomatica. Twelve years of experience in 307 patients (author's transl)].
Kordac V; Martásek P; Kaláb M; Semrádová M; Papezová R
Cas Lek Cesk; 1981 Oct; 120(40):1225-7. PubMed ID: 7344792
[No Abstract] [Full Text] [Related]
20. An injectable corticoid for resistant dermatoses.
Lincoln CS; Nordstrom RC
West Med Med J West; 1966 Jul; 7(7):196-8. PubMed ID: 6013702
[No Abstract] [Full Text] [Related]
[Next] [New Search]
